aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
Year to date, the orthopaedic industry has observed 18 M&A transactions—11 in 1Q16 alone, up one from 10 in 1Q15. Keep track of who/what/where with the M&A spreadsheet. It’s a Membership benefit.
aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
aap Implantate completed the sale of its aapBiomaterials subsidiary. The buyer is Keensight Capital, and aap received proceeds of ~€36.6MM (~€35MM/~US $40MM after transaction costs).
aap is now a pure player in trauma with three platform technologies: LOQTEQ®, silver coating and magnesium.
Year to date, the orthopaedic industry has observed 18 M&A transactions—11 in 1Q16 alone, up one from 10 in 1Q15. Keep track of who/what/where with the M&A spreadsheet. It’s a Membership benefit.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
